Q32 Bio Inc. (QTTB)
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.
$15.56+0.06%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+678.0%
The outlook
Q32 Bio Inc. currently reads as bullish based on strong buy — 1.0 avg of 4 analysts, above its 50- & 200-day averages, 64% of the way from its 52-week low to high, avg target +186% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 4 analysts
Price trendAbove its 50- & 200-day averages
52-week range64% of the way from its 52-week low to high
Price targetAvg target +186% vs current price
Analyst price target
~12-month · 4 analysts$44.50average target+186.0% vs now
Now $15.56
Low $36.00High $66.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$462.3M
52-wk high
$23.57
52-wk low
$1.57
50-day avg
$12.82
200-day avg
$6.41
Trailing P/E
5.6